ea0092ps1-01-05 | Cancer | ETA2023
Baudin Clemence
, Bressand Alice
, Buffet Camille
, Menegaux Fabrice
, Soret Marine
, Broggio David
, Bassinet Celine
, Huet Christelle
, Leenhardt Laurence
, Bernier Marie-Odile
, Lussey-Lepoutre Charlotte
Background: Understanding of changes in salivary and lachrymal gland functions after radioiodine therapy (131I-therapy) remains limited; and, to-date no studies have evaluated dose-response relationships between absorbed dose from 131I-therapy and dysfunctions of these glands. This study investigates salivary/lachrymal dysfunctions in differentiated thyroid cancer (DTC) patients six months after 131I-therapy, identifies 131I-therapy related risk ...